As of 30 Sep 2025, 17 institutional investors reported holding 22,362 shares of TITAN PHARMACEUTICALS INC - COM NEW (TTNP).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 90 | $150 | -$5 | $1.59 | 2 |
| 2025 Q3 | 22,362 | $107,104 | -$53,273 | $5.00 | 17 |
| 2025 Q2 | 37,686 | $158,276 | +$51,725 | $4.00 | 20 |
| 2025 Q1 | 14,708 | $51,920 | +$41,766 | $3.75 | 17 |
| 2024 Q4 | 2,873 | $9,364 | -$69,102 | $3.00 | 13 |
| 2024 Q3 | 16,798 | $88,526 | -$90,493 | $5.25 | 15 |
| 2024 Q2 | 32,190 | $179,301 | +$399 | $5.67 | 17 |
| 2024 Q1 | 32,118 | $229,964 | +$229,929 | $7.00 | 16 |
| 2023 Q4 | 2 | $1 | +$1 | $0.50 | 1 |